A Potential Link Between HLA‐DRB1/DQB1 Alleles and Response to Treatment in Rheumatoid Arthritis Patients
International Journal of Immunogenetics · 2025
DOI: 10.1111/iji.12711 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunogenetics, 2025. Verfasst von Ahmad Tahamoli-Roudsari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Diseases Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, HLA-DRB1 Chains, HLA-DQ beta-Chains. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences.
Abstract (Originalsprache)
The present study aimed to determine the association of HLA‐DRB1/‐DQB1 alleles with response to treatment and anti‐citrullinated peptide antibody (ACPA) status in Iranian rheumatoid arthritis (RA) patients. A total of 167 RA patients, including 114 good responders (GRs) and 53 poor responders (PRs) as well as 330 ethnic‐matched healthy controls, participated in this study. Disease activity and treatment response were assessed using the Disease Activity Score 28‐joint (DAS28) scores during the 9‐month post‐treatment. HLA‐DRB1/‐DQB1 alleles were identified using polymerase chain reaction with a sequence‐specific primers (PCR‐SSP) method and compared between the study groups. Of the patients, 106 (63.5%) were ACPA‐positive, 88 (52.7%) human leucocyte antigen ( HLA )‐shared epitope ( SE )‐positive, 64 (38.3%) ACPA+ SE + and 37 (22.2%) ACPA− SE −. HLA‐SE alleles were significantly more frequent in patients ( p = 3.2e − 05), in PR versus GR patients ( p = 0.01) and in ACPA+ versus ACPA− patients ( p = 0.009). PR patients had a higher prevalence of ACPA+ SE + compared to GR patients ( p = 0.02). Higher frequencies of DRB1*04:02 ( p c = 0.03), *04:04 ( p c = 0.007), *04:05 ( p c = 5.0e − 05), * 10:01 ( p c = 1.0e − 04), DQB1*03:02 ( p c = 0.002) and *05:01 ( p c = 0.002) alleles, and lower frequencies of DRB1*04:01 ( p c = 0.007), *11:01 ( p c = 0.03), *13:01 ( p c = 0.03) and DQB1*06:03 ( p c = 0.03) alleles were observed in patients compared to healthy controls. These findings suggest a relationship between HLA‐SE alleles and ACPA development and a potential link between HLA‐SE /non‐ SE alleles and therapeutic responses in RA patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Diseases Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
- Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
- Cancer Research Center, Institute of Cancer, Avicenna Health Research Institute, Hamadan, Iran.
ORCID-Profile: Ghasem Solgi
Förderung
- Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences
Zitieren
APA
Tahamoli-Roudsari, A., Rasouli-Saravani, A., Basiri, Z., Hajilooi, M., & Solgi, G. (2025). A Potential Link Between HLA‐DRB1/DQB1 Alleles and Response to Treatment in Rheumatoid Arthritis Patients. International Journal of Immunogenetics. https://doi.org/10.1111/iji.12711
Vancouver
Tahamoli-Roudsari A, Rasouli-Saravani A, Basiri Z, Hajilooi M, Solgi G. A Potential Link Between HLA‐DRB1/DQB1 Alleles and Response to Treatment in Rheumatoid Arthritis Patients. International Journal of Immunogenetics. 2025. doi:10.1111/iji.12711
BibTeX
@article{TahamoliRoudsari2025,
author = {Tahamoli-Roudsari, Ahmad and Rasouli-Saravani, Ashkan and Basiri, Zahra and Hajilooi, Mehrdad and Solgi, Ghasem},
title = {A Potential Link Between HLA‐DRB1/DQB1 Alleles and Response to Treatment in Rheumatoid Arthritis Patients},
journal = {International Journal of Immunogenetics},
year = {2025},
doi = {10.1111/iji.12711}
}
EUVIMED